Biology of Platelet-Derived Growth Factor and Its Involvement in Disease
作者： Ricardo H. Alvarez , Hagop M. Kantarjian , Jorge E. Cortes
DOI: 10.4065/81.9.1241
关键词:
摘要: … Platelet-derived growth factor (PDGF) is mainly believed to be an … Platelet-derived growth factor is synthesized by many … , or stimulation by other cytokines and growth factors. In addition, …
mayoclinicproceedings.org
elsevier.com
utsystem.edu参考文章(208)
Gary W. Hoyle, Jian Li, Jeffrey B. Finkelstein, Todd Eisenberg, Jing-Yao Liu, Joseph A. Lasky, Grace Athas, Gilbert F. Morris, Arnold R. Brody, Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor. American Journal of Pathology. ,vol. 154, pp. 1763- 1775 ,(1999) , 10.1016/S0002-9440(10)65432-6
Yasuo Tohma, Catherine Gratas, Wojciech Biernat, Aurelia Peraud, Masakatsu Fukuda, Yasuhiro Yonekawa, Paul Kleihues, Hiroko Ohgaki, PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. Journal of Neuropathology and Experimental Neurology. ,vol. 57, pp. 684- 689 ,(1998) , 10.1097/00005072-199807000-00005
A Maresta, M Balducelli, L Cantini, A Casari, R Chioin, M Fabbri, A Fontanelli, P A Monici Preti, S Repetto, S De Servi, Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. Circulation. ,vol. 90, pp. 2710- 2715 ,(1994) , 10.1161/01.CIR.90.6.2710
Q Hu, A Klippel, A. Muslin, W. Fantl, L. Williams, Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. ,vol. 268, pp. 100- 102 ,(1995) , 10.1126/SCIENCE.7701328
Charles E. Alpers, Ronald A. Seifert, Kelly L. Hudkins, Richard J. Johnson, Daniel F. Bowen-Pope, Developmental patterns of PDGF B-chain, PDGF-receptor, and α-actin expression in human glomerulogenesis Kidney International. ,vol. 42, pp. 390- 399 ,(1992) , 10.1038/KI.1992.300
Hans Michael Kvasnicka, Juergen Thiele, Cordula Werden, Rudolf Zankovich, Volker Diehl, Robert Fischer, Prognostic factors in idiopathic (Primary) osteomyelofibrosis Cancer. ,vol. 80, pp. 708- 719 ,(1997) , 10.1002/(SICI)1097-0142(19970815)80:4<708::AID-CNCR9>3.0.CO;2-I
Gregory N. Fuller, Pathology and Genetics of Tumours of the Nervous System (World Health Organization Classification of Tumours). Advances in Anatomic Pathology. ,vol. 8, pp. 355- 356 ,(2001) , 10.1097/00125480-200111000-00006
E. Joanna Steer, Nicholas C.P. Cross, Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor Beta. Acta Haematologica. ,vol. 107, pp. 113- 122 ,(2002) , 10.1159/000046641
Hans Boström, Karen Willetts, Milos Pekny, Per Levéen, Per Lindahl, Håkan Hedstrand, Marcela Pekna, Mats Hellström, Samuel Gebre-Medhin, Martin Schalling, Mia Nilsson, Siri Kurland, Jan Törnell, John K Heath, Christer Betsholtz, None, PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis Cell. ,vol. 85, pp. 863- 873 ,(1996) , 10.1016/S0092-8674(00)81270-2
Jorge Cortes, Francis Giles, Susan O'Brien, Deborah Thomas, Maher Albitar, Mary Beth Rios, Moshe Talpaz, Guillermo Garcia-Manero, Stefan Faderl, Laurie Letvak, August Salvado, Hagop Kantarjian, Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders† Cancer. ,vol. 97, pp. 2760- 2766 ,(2003) , 10.1002/CNCR.11416